---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-001582"
form_type: "8-K"
ticker: "ZIVO"
cik: "0001101026"
company_name: "Zivo Bioscience, Inc."
filed_at: "2023-02-10T23:59:59+00:00"
generated_at: "2026-06-19T17:32:09.627856+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# ZIVO BIOSCIENCE announces study results; full details not in filing excerpt

## Summary
- Press release dated February 10, 2023 issued regarding results of a recent study.
- Complete text of Exhibit 99.1 is not included in the provided filing excerpt.
- No specific study outcomes, numbers, or conclusions are extractable.

## SEC filing metadata
- accession: 0001654954-23-001582
- form_type: 8-K
- ticker: ZIVO
- cik: 0001101026
- company_name: Zivo Bioscience, Inc.
- filed_at: 2023-02-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1101026/000165495423001582/0001654954-23-001582-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1101026/000165495423001582/zivo_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-001582
- JSON: https://secwatch.observer/filing/0001654954-23-001582.json
- Plain text: https://secwatch.observer/filing/0001654954-23-001582.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.